Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Recombinant human proteoglycan 4 lowers inflammation and atherosclerosis susceptibility in female low-density lipoprotein receptor knockout mice.
J Physiol. 2024 May;602(9):1939-1951. doi: 10.1113/JP286354. Epub 2024 Apr 12.
J Physiol. 2024.
PMID: 38606903
Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.
Greenwood-Van Meerveld B, Mohammadi E, Latorre R, Truitt ER 3rd, Jay GD, Sullivan BD, Schmidt TA, Smith N, Saunders D, Ziegler J, Lerner M, Hurst R, Towner RA.
Greenwood-Van Meerveld B, et al. Among authors: truitt er 3rd.
Urology. 2018 Jun;116:230.e1-230.e7. doi: 10.1016/j.urology.2018.02.034. Epub 2018 Mar 12.
Urology. 2018.
PMID: 29545038
Item in Clipboard
A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye Disease.
Lambiase A, Sullivan BD, Schmidt TA, Sullivan DA, Jay GD, Truitt ER 3rd, Bruscolini A, Sacchetti M, Mantelli F.
Lambiase A, et al. Among authors: truitt er 3rd.
Ocul Surf. 2017 Jan;15(1):77-87. doi: 10.1016/j.jtos.2016.08.004. Epub 2016 Sep 8.
Ocul Surf. 2017.
PMID: 27614318
Clinical Trial.
Item in Clipboard
Cite
Cite